Technical Analysis for EVFM - Evofem Biosciences, Inc.

Grade Last Price % Change Price Change
grade A 4.0 2.56% 0.10
EVFM closed up 2.56 percent on Friday, January 18, 2019, on 18 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. The stock crossed above its 200 day moving average, improving its long-term outlook by crossing above that critical trendline.

Earnings due: Feb 6

0 Watchers
View Intraday Alerts Watchlist Portfolio

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Up
See historical EVFM trend table...

Date Alert Name Type % Chg
Jan 18 20 DMA Support Bullish 0.00%
Jan 18 Crossed Above 200 DMA Bullish 0.00%
Jan 18 Bollinger Band Squeeze Range Contraction 0.00%
Jan 18 NR7 Range Contraction 0.00%
Jan 18 BB Squeeze Started Range Contraction 0.00%
Jan 17 200 DMA Resistance Bearish 2.56%
Jan 17 Crossed Above 20 DMA Bullish 2.56%
Jan 16 Fell Below 200 DMA Bearish 5.26%
Jan 16 Fell Below 20 DMA Bearish 5.26%
Jan 16 50 DMA Support Bullish 5.26%

Older signals for EVFM ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Analyze My Stocks!
Configure default chart indicators
Basic chart:

Profile
Neothetics Inc is a clinical-stage pharmaceutical company developing therapeutics for the aesthetic market. Its product is a novel injectable treatment for the reduction of central abdominal bulging due to subcutaneous fat in non-obese patients.
Is EVFM a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Date Title
Jan 7 Evofem Biosciences, Amphora a Potential New Birth Control, Analysts Review and Target
Jan 3 Evofem Biosciences Provides Corporate Update and Announces Upcoming Milestones
Dec 24 60 Biggest Movers From Friday
Dec 20 The Zacks Analyst Blog Highlights: Amgen, Aduro, Vertex, Evofem and Incyte
Dec 19 Biotech Stock Roundup: Pipeline Updates From VRTX & AMGN, ADRO Teams Up With LLY
Dec 18 Evofem Shares Up as Birth Control Gel Succeeds in Phase III
Dec 18 Today's Research Reports on Trending Tickers: Evofem Biosciences and Diffusion Pharmaceuticals
Dec 17 4 Stocks Providing Investor Opportunity Right Now
Dec 17 40 Stocks Moving In Monday's Mid-Day Session
Dec 17 Axovant Sciences among healthcare gainers; Sophiris Bio and Molina Healthcare among losers
See more EVFM news...
Indicators
Indicator Value
52 Week High 12.0
52 Week Low 1.79
Average Volume 142,786
200-Day Moving Average 3.8989
50-Day Moving Average 3.6963
20-Day Moving Average 3.9113
10-Day Moving Average 3.886
Average True Range 0.3104
ADX 13.29
+DI 15.7461
-DI 14.6133
Chandelier Exit (Long, 3 ATRs ) 3.2938
Chandelier Exit (Short, 3 ATRs ) 4.0912
Upper Bollinger Band 4.2618
Lower Bollinger Band 3.5608
Percent B (%b) 0.63
BandWidth 17.92243
MACD Line 0.0483
MACD Signal Line 0.0613
MACD Histogram -0.0129
Fundamentals Value
Market Cap 55.31 Million
Num Shares 13.8 Million
EPS -0.74
Price-to-Earnings (P/E) Ratio -5.41
Price-to-Sales 0.00
Price-to-Book 2.76
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 4.27
Resistance 3 (R3) 4.24 4.12 4.23
Resistance 2 (R2) 4.12 4.05 4.14 4.21
Resistance 1 (R1) 4.06 4.01 4.09 4.09 4.19
Pivot Point 3.94 3.94 3.96 3.96 3.94
Support 1 (S1) 3.88 3.87 3.91 3.91 3.81
Support 2 (S2) 3.76 3.83 3.78 3.79
Support 3 (S3) 3.70 3.76 3.78
Support 4 (S4) 3.73